TGTX icon

TG Therapeutics

115 hedge funds and large institutions have $272M invested in TG Therapeutics in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

4.25% less ownership

Funds ownership: 55.31%51.06% (-4.2%)

37% less capital invested

Capital invested by funds: $434M → $272M (-$162M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
115
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.3M
Puts
$2.19M
Net Calls
Net Calls Change

Top Buyers

1 +$12.1M
2 +$2.65M
3 +$1.99M
4
BlackRock
BlackRock
New York
+$1.7M
5
Northern Trust
Northern Trust
Illinois
+$1.22M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$343K
52
$318K
53
$316K
54
$305K
55
$291K
56
$281K
57
$276K
58
$273K
59
$218K
60
$212K
61
$210K
62
$195K
63
$176K
64
$168K
65
$164K
66
$159K
67
$153K
68
$153K
69
$152K
70
$148K
71
$145K
72
$139K
73
$129K
74
$128K
75
$119K